Afinitor (Everolimus)
everolimus 2 mg dispersible tablet, 30 · ORAL · PBS code 11591C
AUTHORITY_REQUIREDWhat it costs
AU$318.6 PBS-determined price per 30 units
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2019-01-01.
- • Repeats: 5.
- • PBS program: GE.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Refractory seizures associated with tuberous sclerosis complex
Initial treatment
Patient must have a confirmed diagnosis of tuberous sclerosis complex (TSC); AND
Patient must be experiencing a minimum of two partial-onset seizures per week; AND
The condition must have failed to be controlled satisfactorily at stable doses of at least two antiseizure medications; AND
The treatment must be in combination with at least one antiseizure medication; AND
Patient must not be a candidate for curative surgery; AND
Patient must be at least 2 years of age.
Sponsor: Novartis Pharmaceuticals Australia Pty Limited ABN 18 004 244 160
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.